This is the authors' abstract. We don't add key points for this paper.
miR-486-5p nanoparticles protect kidney cells in an in vitro AKI injury model and have the potential to develop miRNA-based nanotherapies for AKI applications.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Maadelat et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: